Posts Tagged 'Atorvastatin'

ISMP: Number of Lipitor Lawsuits Merits Re-Examination

number of lipitor lawsuits may cause re-evaluation of safety of drugThe Institute of Safe Medication Practices (ISMP) has released the 2015 Annual QuarterWatch drug safety report, providing an overview of domestic drug-related adverse events as submitted to the U.S. Food and Drug Administration (FDA) in 2014. In it, the ISMP considered the high number of Lipitor diabetes lawsuits that have accumulated and what they may indicate about the safety of statins like Lipitor.

Lipitor ...

continue reading...

Maker of generic Lipitor sued

Indian company Ranbaxy Laboratories is being sued by a New Jersey man over its decision to recall a generic version of the cholesterol medication Lipitor because glass particles were found in some lots.

According to a report on Pharmalot, the recall was made only at the pharmacy level, which means consumers were not directly notified of the problem or how to respond if they became aware of it. The New Jersey ...

continue reading...

Glass found in cholesterol medication

The India-based manufacturer of a generic version of cholesterol medication Lipitor has issued a recall after tiny pieces of glass were found in some of its tablets.

The medication in question is called Atorvastatin, made by Ranbaxy Pharmaceuticals Inc., according to an ABC News report.

The U.S. Food and Drug Administration announced that the company will halt production of Atorvastatin “until it has thoroughly investigated the cause of the glass particulates and remedied the problem.”

The report says that the glass particles discovered ...

continue reading...